Related Experiment Video
Updated: Jul 20, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes
Geoffrey P Garnett1, Jane J Kim, Katherine French
1Department of Infectious Disease Epidemiology, Imperial College London, St. Mary's Campus, Norfolk Place, London, UK. g.garnett@imperial.ac.uk
Abstract:
The impact of human papillomavirus (HPV)-16/18 vaccination on the incidence of infection and disease can be explored in a range of different models. Here we explore the epidemiological and economic impact of vaccination where screening is absent and where it is well established. The importance for epidemiology of assumptions about naturally-acquired immunity and heterogeneity in risk behaviours are highlighted, as are the importance for health economic outcomes of vaccine costs and the ability to modify screening strategies. To date, model results are consistent in predicting a useful role for vaccine, but further epidemiological data are required to help test the validity of models.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results from...
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Preventive Healthcare Services
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers